DXC Q1 Revenue Beats, But EPS Misses and Organic Decline Persists; Full-Year FCF Guidance Raised

summarizeSummary

DXC Technology's Q1 FY27 revenue of $3.00B beat consensus, but adjusted EPS of $0.40 missed estimates and fell 41% YoY. Organic revenue declined 6.7%, and full-year guidance was maintained except for a raised free cash flow outlook due to litigation proceeds.

check_boxKey Events · Earnings and Guidance · DXC

• Q1 Revenue Beat, EPS Miss

  Revenue of $3.00B slightly exceeded the $2.99B consensus, but non-GAAP diluted EPS of $0.40 missed estimates and declined 41.2% YoY, driven by margin compression.

• Organic Revenue Decline Accelerates

  Organic revenue fell 6.7% YoY, with GIS segment organic revenue down 11.1%, reflecting ongoing demand weakness and competitive pressures.

• Full-Year Guidance Maintained, FCF Raised

  FY27 revenue guidance of $12.10B-$12.35B and non-GAAP EPS of $2.40-$2.90 were reiterated, but free cash flow guidance was raised to ~$685M from ~$600M due to a $214M litigation-related cash inflow.

• Share Repurchases Continue

  DXC repurchased $70M of shares (~6.7M shares) in Q1, reducing the diluted share count to 166.27M from 184.96M a year ago.

auto_awesomeAnalysis · DXC · Technology

DXC Technology reported Q1 FY27 revenue of $3.00 billion, slightly above the $2.99 billion consensus, but adjusted EPS of $0.40 missed estimates by a wide margin and fell 41% year-over-year. Organic revenue declined 6.7%, driven by an 11.1% drop in the GIS segment. The company maintained full-year revenue and EPS guidance but raised free cash flow guidance to ~$685 million, reflecting a $214 million litigation-related cash inflow. The results highlight ongoing top-line pressure and margin compression, though the improved cash flow outlook and $70 million in share repurchases provide some offset. The stock is likely to react negatively to the EPS miss and persistent organic decline, despite the revenue beat and raised cash flow forecast.